Oxeladin hydrogen citrate is a synthetic antitussive agent classified as a butyric acid ester derivative, primarily utilized to suppress dry or non-productive coughs by acting on the respiratory center.… Read more





Oxeladin hydrogen citrate is a synthetic antitussive agent classified as a butyric acid ester derivative, primarily utilized to suppress dry or non-productive coughs by acting on the respiratory center. As a critical pharmaceutical component, this category provides high-quality reference standards for oxeladin hydrogen citrate, alongside its specific degradation products and related substances. Pharmaceutical laboratories rely on these reference materials, including pharmacopeial and non-pharmacopeial impurities such as Impurity A, Impurity B, and the N-oxide metabolite, to conduct rigorous impurity profiling and method validation. These compounds are essential for maintaining strict quality control and performing accurate stability studies during the analytical testing of the active pharmaceutical ingredient. By utilizing these precise analytical standards and stable isotope labelled compounds, researchers and manufacturers can ensure the efficacy, safety, and regulatory compliance of their formulations throughout the development lifecycle.